Founded in 2000, VelocityHealth Securities operates a boutique investment banking firm focused on companies within all healthcare sectors including: biotechnology, diagnostics, distribution, health care information technology (HCIT), health care services, medical devices, and all areas of pharmaceuticals such as drug delivery, generics and specialty pharma. VHS offers mergers and acquisitions advisory services for sponsors and companies with enterprise value transactions from $5 million to $500 million, including buy-sides, recapitalizations, sell-sides and fairness opinions. Our capital markets team also advises companies seeking capital including public and private equity, subordinated debt, and senior debt. Our typical equity/debt client is seeking between $5 million to $200 million in capital. Additionally, VHS offers advisory services for companies regarding business development and strategic relationships such as: in-licensing and out-licensing of products and technologies, channel partners, and corporate partnering. Our relationships and clients are national and international in scope, including European, Indian, Asian, and emerging markets. VelocityHealth Securities, Inc. is a registered broker/dealer and member of the Financial Industry Regulatory Authority (FINRA) and a member of the SIPC.